RECRUITING

Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Acute gastrointestinal bleeding is potentially lethal in liver cirrhosis. Accurate assessment of prognosis is critical in a timely fashion. A novel model, CAGIB score, has been developed based on our Chinese multicenter retrospective study. Now, a prospective, international multicenter, observational study will be performed to further compare the performance of CAGIB versus Child-Pugh and MELD scores for evaluating the in-hospital mortality of patients with liver cirrhosis and acute gastrointestinal bleeding.

Official Title

Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding: A Prospective, International Multicenter, Observational Study

Quick Facts

Study Start:2022-01-01
Study Completion:2024-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04662918

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Patients with liver cirrhosis;
  2. 2. Patients with acute gastrointestinal bleeding presenting with hematemesis, melena, and/or hematochezia;
  3. 3. Adults (age≥18 years old).
  1. 1. Components of Child-Pugh, MELD, and CAGIB scores are not available;
  2. 2. In-hospital outcomes are not evaluable.

Contacts and Locations

Study Contact

Xingshun Qi, Dr.
CONTACT
18909881019
xingshunqi@126.com
Zhaohui Bai, Dr.
CONTACT
18524451863
bai_zhao_hui@foxmail.com

Study Locations (Sites)

The Wright Center for Graduate Medical Education, 501 S. Washington Avenue
Scranton, Pennsylvania, 18503
United States

Collaborators and Investigators

Sponsor: Xingshun Qi

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-01-01
Study Completion Date2024-12

Study Record Updates

Study Start Date2022-01-01
Study Completion Date2024-12

Terms related to this study

Additional Relevant MeSH Terms

  • GastroIntestinal Bleeding